John Dotis, Charalampos Antachopoulos, Vasiliki Karava, Athina Papadopoulou, Nikoleta Printza
{"title":"Moraxella peritoneal dialysis-related infections: a systematic review.","authors":"John Dotis, Charalampos Antachopoulos, Vasiliki Karava, Athina Papadopoulou, Nikoleta Printza","doi":"10.1590/2175-8239-JBN-2025-0246en","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Moraxella species, although infrequent in peritoneal dialysis (PD)-associated infections, are established pathogens. Moraxella catarrhalis is recognized as a cause of upper and lower respiratory tract infections and is increasingly associated with β-lactamase production. The role of Moraxella species in PD-related infections warrants further investigation.</p><p><strong>Methods: </strong>A comprehensive search of PubMed and Google Scholar was conducted for cases of PD-associated infections caused by Moraxella. Inclusion criteria required a diagnosis of peritonitis or exit-site infection confirmed by culture. Demographic data, clinical presentation, microbiological identification, antimicrobial resistance, therapeutic regimens, and outcomes were analyzed.</p><p><strong>Results: </strong>Fourteen cases of Moraxella-related peritonitis in PD patients were identified between 1987 and 2024 from 13 studies, with no reports of exitsite infections. The mean age was 56 years; diabetic nephropathy was the most common underlying condition (four cases). M. catarrhalis (n = 6) and Moraxella osloensis (n = 5) were the most frequent pathogens. The most commonly reported methods were bacterial growth in culture media, followed by species identification using biochemical profiling or automated systems (n = 10), and advanced confirmatory techniques. Clinical presentation included abdominal pain, fever, and clouding of the dialysis fluid. Most isolates were susceptible to cephalosporins, aminoglycosides, and fluoroquinolones. The majority of patients (86%) retained their catheters after appropriate treatment, usually with intraperitoneal cephalosporins, achieving complete symptom resolution within a few days. Overall prognosis was favorable, with no mortality.</p><p><strong>Conclusion: </strong>Moraxella species, although rare, should be considered in the differential diagnosis of PD-associated infections. Identification using advanced techniques allows effective treatment and favorable outcomes, often without the need for catheter removal.</p>","PeriodicalId":14724,"journal":{"name":"Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia","volume":"48 2","pages":"e20250246"},"PeriodicalIF":1.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12987636/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/2175-8239-JBN-2025-0246en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Moraxella species, although infrequent in peritoneal dialysis (PD)-associated infections, are established pathogens. Moraxella catarrhalis is recognized as a cause of upper and lower respiratory tract infections and is increasingly associated with β-lactamase production. The role of Moraxella species in PD-related infections warrants further investigation.
Methods: A comprehensive search of PubMed and Google Scholar was conducted for cases of PD-associated infections caused by Moraxella. Inclusion criteria required a diagnosis of peritonitis or exit-site infection confirmed by culture. Demographic data, clinical presentation, microbiological identification, antimicrobial resistance, therapeutic regimens, and outcomes were analyzed.
Results: Fourteen cases of Moraxella-related peritonitis in PD patients were identified between 1987 and 2024 from 13 studies, with no reports of exitsite infections. The mean age was 56 years; diabetic nephropathy was the most common underlying condition (four cases). M. catarrhalis (n = 6) and Moraxella osloensis (n = 5) were the most frequent pathogens. The most commonly reported methods were bacterial growth in culture media, followed by species identification using biochemical profiling or automated systems (n = 10), and advanced confirmatory techniques. Clinical presentation included abdominal pain, fever, and clouding of the dialysis fluid. Most isolates were susceptible to cephalosporins, aminoglycosides, and fluoroquinolones. The majority of patients (86%) retained their catheters after appropriate treatment, usually with intraperitoneal cephalosporins, achieving complete symptom resolution within a few days. Overall prognosis was favorable, with no mortality.
Conclusion: Moraxella species, although rare, should be considered in the differential diagnosis of PD-associated infections. Identification using advanced techniques allows effective treatment and favorable outcomes, often without the need for catheter removal.